ON July 21, 2022, U.S. President Joe Biden said he had tested positive for COVID-19 and was experiencing mild symptoms. In a letter to the public, Biden’s doctor explained that the president had a slight runny nose, some fatigue and the occasional dry cough, and that Biden had already begun taking the antiviral drug Paxlovid.
Patrick Jackson, an assistant professor of infectious diseases at the University of Virginia, explains the risks that someone like Biden faces from a bout of COVID-19 and the treatments available.
The most important risk factor for developing severe COVID-19 is age. If you are 79 years old when you become infected with COVID-19, like President Biden, you are eight times more likely to become hospitalized and 140 times more likely to die compared with someone who gets COVID-19 at age 20.
Preexisting health conditions – like obesity, cancer and chronic kidney or lung disease – also increase the risk of severe illness. But Biden is reported to be fairly healthy.
Fortunately, preexisting immunity from vaccination or from a previous episode of COVID-19 is highly protective against severe disease. Researchers only have limited data on the BA.5 variant that is responsible for most recent COVID-19 cases in the U.S. – and likely Biden’s, too – but the level of protection from vaccines is likely similar to that of the previous strains BA.1 and BA.2.
While the BA.1 and BA.2 omicron variants of SARS-CoV-2 were very adept at infecting people who are vaccinated and boosted, the data shows that prior immunity from vaccines provides strong protection against severe or fatal disease.
During the first omicron wave in California, COVID-19 patients who did not have immunity from vaccination or previous infection were much more likely to be hospitalized, be admitted into an intensive care unit or die compared with people who were vaccinated and boosted.
Current best medical practice is to give antiviral treatments to patients who have recently developed mild to moderate COVID-19 symptoms and are at higher risk of severe illness. The goal of antivirals is to stop the virus from replicating in the body in order to prevent hospitalization or death.
Currently there are four antiviral drugs available in the U.S. for the treatment of COVID-19 in outpatients: nirmatrelvir-ritonavir, better known by the brand name Paxlovid, remdesivir, bebtelovimab and molnupiravir. The best drug for a particular patient depends on preexisting health conditions, accessibility and drug interactions with other medications. Paxlovid is widely used because it was shown to be highly effective in a clinical trial and is available in pill form.
Paxlovid is an oral antiviral drug that is used to treat some patients with mild to moderate COVID-19 who do not require hospitalization. Paxlovid is a combination of two medications. One is nirmatrelvir, a drug that works by disrupting the coronavirus’ ability to make functioning proteins. The other is ritonavir, an HIV drug that boosts the level of nirmatrelvir in the blood by blocking an enzyme in the liver that breaks down nirmatrelvir.
A clinical trial of Paxlovid showed that the drug significantly reduces the risk of hospitalization or death when given to infected patients within five days of their first COVID-19 symptoms. This trial looked at Paxlovid given to people who had no prior immunity to COVID-19 from vaccines or previous infection.
The effectiveness of Paxlovid in the treatment of patients who have preexisting immunity from vaccination or prior infection is less clear, though some studies suggest that older vaccinated patients may still benefit from the drug. Paxlovid has not been found to reduce symptoms or make patients feel better more quickly.
Paxlovid is not a panacea. It cannot be used for some patients who have significant kidney or liver problems, and it interacts negatively with a large number of other medications. Some patients cannot take Paxlovid because of the other drugs they use, but physicians can sometimes manage these interactions.
For example, Biden is reportedly taking a blood thinner called apixaban. This drug interacts negatively with Paxlovid. It is likely Biden’s doctor has instructed him to reduce his dose of apixaban or stop it briefly while on Paxlovid.
Biden’s doctors will be monitoring his symptoms and checking his blood oxygen level. If Biden’s symptoms – like cough, shortness of breath or fever – worsen or he needs supplemental oxygen, it is possible he would be hospitalized where he may get treated with additional drugs, including steroids.
Some patients experience an initial improvement followed by a “rebound” of their COVID-19 symptoms. It is not clear how often rebounds happen or if they are associated with COVID-19 treatment. Rebounds appear to be generally mild and not associated with hospitalization or death, though they can prolong the required period of isolation.
It is still too early to tell how mild or severe Biden’s bout of COVID-19 will be. With most mild cases only lasting around a week, the U.S. should only need to wait a few days to get a sense of what kind of fight the president is facing.
Reuters
Fri Jul 22 2022
Biden's doctor explained that the president had a slight runny nose, some fatigue and the occasional dry cough, and that Biden had already begun taking the antiviral drug Paxlovid. - Filepic
Lebih 2,300 hektar kawasan lapang di ibu negara diperuntukkan kawasan hijau
Daripada keluasan itu, sebanyak 977.55 hektar tanah telah diwartakan, manakala 1,416.24 hektar tanah lapang yang berpotensi akan dan sedang dalam proses diwartakan.
Guna jawatan untuk projek pembekalan, suami isteri ditahan
Sepasang suami isteri direman enam hari dalam siasatan penyalahgunaan jawatan untuk mendapatkan projek pembekalan bernilai lebih RM200,000.
Perintah reman dikeluarkan Majistret Noor Mazrinie Mahmood bermula hari ini hingga Ahad.
Perintah reman dikeluarkan Majistret Noor Mazrinie Mahmood bermula hari ini hingga Ahad.
DBKL ubah lalu lintas Jalan Sultan Ismail bermula 22 Julai
Dewan Bandaraya Kuala Lumpur (DBKL) akan melaksanakan perubahan lalu lintas di Jalan Sultan Ismail berkuat kuasa 22 Julai ini.
ADUN Rembia sertai Pas, kenapa tak umum tahun lepas? - MP Kampar
Tindakan tersebut seolah-olah satu penghinaan paling besar kepada Parlimen yang telah meluluskan pindaan Perlembagaan Persekutuan berkait Akta Antilompat Parti.
[TERKINI] Perbelanjaan pengguna Malaysia dijangka kembali teguh
Perbelanjaan pengguna Malaysia dijangka teguh sepanjang tahun ini, demikian menurut BMI, iaitu syarikat Fitch Solitions.
Kes bunuh Nur Farah Kartini: Suspek berkhidmat 5 tahun dalam PDRM
Anggota berusia 26 tahun terbabit bertugas di Balai Polis Slim River di bawah Ibu Pejabat Polis Daerah (IPD) Muallim dengan pangkat lans koperal.
Perunding pelaburan didakwa terlibat pengubahan wang haram hampir RM1 juta
Seorang perunding pelaburan mengaku tidak bersalah atas empat pertuduhan pengubahan wang haram berjumlah hampir RM1 juta.
Purata suhu meningkat 0.24 darjah celcius per dekad
Berdasarkan rekod dari tahun 1969 hingga 2019, purata suhu bulanan di Semenanjung Malaysia pada bulan Mei 2024 adalah 28.8 darjah celcius manakala purata suhu bulanan pada bulan Mei 1974 iaitu 50 tahun yang lalu adalah 26.6 darjah celcius.
ADUN dari kerajaan perpaduan sertai Pas
Menurut Takiyuddin, keahlian Muhamad Jailani yang juga wakil rakyat UMNO diterima pada 10 Jun tahun lalu, namun diumumkan secara rasmi hari ini.
Kerajaan lihat semula perjanjian penjualan air kepada Singapura - Fadillah
Fadillah berkata perkara itu sudah berlaku ketika zaman pentadbiran bekas Perdana Menteri Tun Dr Mahathir Mohamad lagi.
Biden seru redakan retorik politik di AS selepas cubaan bunuh Trump
Sudah tiba masanya untuk meredakan retorik politik di Amerika Syarikat (AS), kata Presiden Joe Biden semasa ucapan mengenai cubaan membunuh bekas Presiden Donald Trump.
Biden gesa siasatan bebas berhubung insiden tembakan Trump
Presiden Amerika Syarikat (AS) Joe Biden menyeru agar rakyat negara itu bersatu susulan cubaan membunuh terhadap Donald Trump.
Trump ditembak: 'Tindakan tidak bermoral jika hanya gimik' - Penganalisis
Pakar geopolitik Universiti Utara Malaysia (UUM), Awang Dzul-Hashriq Dharfizi, tidak percaya serangan tembakan terhadap Donald Trump adalah gimik.
Biden kecam serangan ke atas Trump
Tegas beliau, tiada ruang untuk keganasan di negara itu dan beliau mahu semua pihak mengecam insiden tersebut.
Trump ditembak ketika kempen
Calon presiden Republikan itu dilihat mengangkat penumbuk ketika diiringi ke kenderaan oleh Perkhidmatan Rahsia negara.
'Saya calon paling layak bertanding jawatan presiden' - Biden
Biden membuat kenyataan itu sebagai respons terhadap desakan yang semakin meningkat, menggesa beliau menarik diri.
Biden tersilap perkenal Zelenskyy sebagai Putin pada sidang kemuncak NATO
Kesilapan Presiden Biden menjelang sidang akhbar yang ditunggu-tunggu boleh menentukan nasibnya dalam pilihan raya.
George Clooney gesa Biden tarik diri daripada pilihan raya
Pengumpul dana Demokrat terkemuka Clooney ikut jejak Nancy Pelosi yang mempersoal apakah perlu Biden teruskan hasrat lawan Donald Trump.
Biden komited tamatkan penggal kedua sekiranya menang - Rumah Putih
Biden berdepan desakan untuk menarik balik pencalonannya sejak prestasi buruknya menentang Trump dalam debat presiden pertama mereka pada 27 Jun.
Trump cabar Biden sertai debat tanpa moderator
Donald Trump dakwa, Demokrat sedang mengalami "keruntuhan besar-besaran" dan cabar Joe Biden untuk tampil dalam satu lagi sesi debat.